Nanoparticle-based therapeutics: An overview

Ocular Drug Delivery Systems: Barriers and Application of Nanoparticulate Systems

Volumn , Issue , 2012, Pages 3-15

  Thassu, Deepak ^a   Holt, Kris ^b   Chader, Gerald J ^c  

^a Actavis SSL R and D   (United States)

^b Vice President Pharmaceutical Development Pharmanova Inc   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85055840714     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/b12950     Document Type: Chapter

References (9)

1. Boron, W. F., & Boulpaep, E. L. (2009). Medical Physiology: A Cellular and Molecular Approach. Philadelphia, PA: Elsevier/Saunders.
2. Credit Suisse Securities (Europe) Limited. (2008). The Size of Things to Come: The Rise of Nanotechnology in Healthcare. London: Credit Suisse Securities (Europe) Limited.
3. Herrera, J. E., & Sakulchaicharoen, N. (2009). Microscopic and Spectorscopic Characterization of Nanoparticles. In Y. Pathak, & D. Thassu, Drug Delivery Nanoparticles Formulation and Characterization (pp. 239-251). New York: Informa Healthcare.
4. Hughes, P. M., & Mitra, A. K. (1993). Overview of Cular Drug Delivery and Iatogenic Cytopathologies. New York: Marcel Dekker.
5. Merchant, M. (2010). Nanotechnology in Healthcare. London: Business Insights, Ltd.
6. Royal Society. (2004). Nanoscience and Nanotechnologies: Opportunities and Uncertainties, p. 4. London: The Royal Society.
7. Silver Colloids. 2010. The Electric Double Layer. Retrieved September 9, 2011, from http://www.silver-colloids.com/Tutorials/Intro/pcs17.html
8. Thassu, D., Deleers, M., & Pathak, Y. (2007). Nanoparticulate Drug Delivery Systems. New York: Informa Healthcare.
9. Thassu, D., Holt, K., & Hermans, D. (2010). Surface Modified Nanoparticles Enhance Delivery of Poorly Soluble Drugs. Poster at CRS symposium on Poorly Soluble Drugs.